Back to search

Article

New coumarin-piperazine derivatives alleviate inflammatory bowel diseases as IL-6 inhibitors by targeting NF-κB pathway

2026-07-14

Abstract excerpt

<title>Abstract</title> <p> Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory disease that is difficult to cure. In present work, a series of new coumarin-piperazine derivatives have been designed and prepared, and their anti-inflammatory activities and mechanism have been investigated. The results revealed that some compounds showed excellent inhibition effect on NO generation with low IC <...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
55d85723-25d2-5a01-8ac6-ea8536f73bc1
DOI
10.21203/rs.3.rs-10278709/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
New coumarin-piperazine derivatives alleviate inflammatory bowel diseases as IL-6 inhibitors by targeting NF-κB pathwayDOI 10.21203/rs.3.rs-10278709/v1
Select a neighboring publication to make it the new centre.